Schwartz JC - Search Results

1

Structure-activity studies with histamine H3-receptor ligands.

Ganellin CR, Fkyerat A, Hosseini SK, Khalaf YS, Piripitsi A, Tertiuk W, Arrang JM, Garbarg M, Ligneau X, Schwartz JC. Ganellin CR, et al. Among authors: schwartz jc. J Pharm Belg. 1995 Mar-Jun;50(2-3):179-87. J Pharm Belg. 1995. PMID: 7674117 Review.

2

Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.

Pelloux-Léon N, Fkyerat A, Piripitsi A, Tertiuk W, Schunack W, Stark H, Garbarg M, Ligneau X, Arrang JM, Schwartz JC, Ganellin CR. Pelloux-Léon N, et al. Among authors: schwartz jc. J Med Chem. 2004 Jun 3;47(12):3264-74. doi: 10.1021/jm031141p. J Med Chem. 2004. PMID: 15163206

3

Design of potent non-thiourea H3-receptor histamine antagonists.

Ganellin CR, Hosseini SK, Khalaf YS, Tertiuk W, Arrang JM, Garbarg M, Ligneau X, Schwartz JC. Ganellin CR, et al. Among authors: schwartz jc. J Med Chem. 1995 Aug 18;38(17):3342-50. doi: 10.1021/jm00017a018. J Med Chem. 1995. PMID: 7650687

4

A novel series of (phenoxyalkyl)imidazoles as potent H3-receptor histamine antagonists.

Ganellin CR, Fkyerat A, Bang-Andersen B, Athmani S, Tertiuk W, Garbarg M, Ligneau X, Schwartz JC. Ganellin CR, et al. Among authors: schwartz jc. J Med Chem. 1996 Sep 13;39(19):3806-13. doi: 10.1021/jm960138l. J Med Chem. 1996. PMID: 8809168

5

Synthesis of potent non-imidazole histamine H3-receptor antagonists.

Ganellin CR, Leurquin F, Piripitsi A, Arrang JM, Garbarg M, Ligneau X, Schunack W, Schwartz JC. Ganellin CR, et al. Among authors: schwartz jc. Arch Pharm (Weinheim). 1998 Dec;331(12):395-404. doi: 10.1002/(sici)1521-4184(199812)331:12<395::aid-ardp395>3.0.co;2-7. Arch Pharm (Weinheim). 1998. PMID: 9923195

6

Development of a new class of nonimidazole histamine H(3) receptor ligands with combined inhibitory histamine N-methyltransferase activity.

Apelt J, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Apelt J, et al. Among authors: schwartz jc. J Med Chem. 2002 Feb 28;45(5):1128-41. doi: 10.1021/jm0110845. J Med Chem. 2002. PMID: 11855993

7

Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.

Sasse A, Ligneau X, Rouleau A, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Sasse A, et al. Among authors: schwartz jc. J Med Chem. 2002 Aug 29;45(18):4000-10. doi: 10.1021/jm020910m. J Med Chem. 2002. PMID: 12190321

8

Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.

Mikó T, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H. Mikó T, et al. Among authors: schwartz jc. J Med Chem. 2003 Apr 10;46(8):1523-30. doi: 10.1021/jm021084k. J Med Chem. 2003. PMID: 12672253

9

Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.

Mikó T, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Mikó T, et al. Among authors: schwartz jc. Bioorg Med Chem. 2004 May 15;12(10):2727-36. doi: 10.1016/j.bmc.2004.03.009. Bioorg Med Chem. 2004. PMID: 15110854

10

4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.

Meier G, Krause M, Hüls A, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H. Meier G, et al. Among authors: schwartz jc. J Med Chem. 2004 May 6;47(10):2678-87. doi: 10.1021/jm031065q. J Med Chem. 2004. PMID: 15115409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters